Eriocalyxin B TN1620
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways, should be considered a candidate for pancreatic cancer treatment; it is a specific inhibitor of STAT3, it directly target
CAS nr:
84745-95-9
Purity:
98%
Molecular Weight:
344,4
SMILES:
[H][C@@]12CC[C@@H]3C[C@]1(C(=O)C3=C)[C@@]1(O)OC[C@]22C(=O)C=CC(C)(C)[C@@]2([H])[C@@H]1O
Formula:
C20H24O5
Pathway:
GPCR/G Protein,JAK/STAT signaling,Stem Cells,NF-_b,Apoptosis
Target:
cAMP,STAT,STAT,NF-_B,Apoptosis
